Brussels’ beleaguered coronavirus vaccination program could be poised to get a shot in the arm as the EU’s central regulator completes its initial stage in appraising Sputnik V, the vaccine developed by Moscow’s Gamaleya Center.
The European Medicines Agency (EMA) told Russian media on Tuesday that the scientific consultation process was now finalized. “As a next step, the company can prepare an application for a registration certificate” for the EU market, a source at the agency informed RIA Novosti.
Continue reading https://on.rt.com/b1do